[1]
S. N. Martínez, “Safety and Immunogenicity of a PHH-1V Booster Dose after Different Prime Vaccination Schemes against Covid-19: Phase III Clinical Trial Final Results Up To One Year”, acbr, vol. 8, no. 4, pp. 326–342, Aug. 2024.